共 50 条
- [44] When marginal costs and benefits should be used in screening BRITISH MEDICAL JOURNAL, 1996, 312 (7037): : 1041 - 1042
- [47] Neoadjuvant Therapy Should Not Be Used as Part of Standard Clinical Practice ONCOLOGY-NEW YORK, 2018, 32 (01): : 39 - +
- [48] THE TIPPING POINT: WHEN SHOULD A MODIFICATION BECOME THE STANDARD TECHNIQUE? JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 152 (01): : 288 - 289